TEMPUS AI INC (TEM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:TEM • US88023B1035

55.19 USD
+2.75 (+5.24%)
Last: Feb 6, 2026, 12:03 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TEM. TEM was compared to 57 industry peers in the Life Sciences Tools & Services industry. While TEM seems to be doing ok healthwise, there are quite some concerns on its profitability. TEM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TEM had negative earnings in the past year.
  • In the past year TEM has reported a negative cash flow from operations.
  • In the past 5 years TEM always reported negative net income.
  • TEM had a negative operating cash flow in each of the past 5 years.
TEM Yearly Net Income VS EBIT VS OCF VS FCFTEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • TEM's Return On Assets of -8.94% is in line compared to the rest of the industry. TEM outperforms 47.37% of its industry peers.
  • With a Return On Equity value of -40.15%, TEM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.94%
ROE -40.15%
ROIC N/A
ROA(3y)-60.21%
ROA(5y)-54.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TEM Yearly ROA, ROE, ROICTEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • With an excellent Gross Margin value of 61.73%, TEM belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
  • TEM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TEM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y16.28%
TEM Yearly Profit, Operating, Gross MarginsTEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • TEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TEM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TEM Yearly Shares OutstandingTEM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TEM Yearly Total Debt VS Total AssetsTEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.27 indicates that TEM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • TEM has a better Altman-Z score (2.27) than 63.16% of its industry peers.
  • A Debt/Equity ratio of 2.45 is on the high side and indicates that TEM has dependencies on debt financing.
  • TEM's Debt to Equity ratio of 2.45 is on the low side compared to the rest of the industry. TEM is outperformed by 87.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACC11.03%
TEM Yearly LT Debt VS Equity VS FCFTEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 3.28 indicates that TEM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.28, TEM is in line with its industry, outperforming 57.89% of the companies in the same industry.
  • A Quick Ratio of 3.12 indicates that TEM has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.12, TEM is in the better half of the industry, outperforming 61.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 3.12
TEM Yearly Current Assets VS Current LiabilitesTEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 85.75% over the past year.
  • TEM shows a strong growth in Revenue. In the last year, the Revenue has grown by 72.58%.
  • Measured over the past years, TEM shows a very strong growth in Revenue. The Revenue has been growing by 62.05% on average per year.
EPS 1Y (TTM)85.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56%
Revenue 1Y (TTM)72.58%
Revenue growth 3Y39.06%
Revenue growth 5Y62.05%
Sales Q2Q%84.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.74% on average over the next years. This is a very strong growth
  • TEM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.70% yearly.
EPS Next Y75.39%
EPS Next 2Y35.63%
EPS Next 3Y28.93%
EPS Next 5Y24.74%
Revenue Next Year81.58%
Revenue Next 2Y50.22%
Revenue Next 3Y39.5%
Revenue Next 5Y32.7%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TEM Yearly Revenue VS EstimatesTEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
TEM Yearly EPS VS EstimatesTEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • TEM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TEM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TEM Price Earnings VS Forward Price EarningsTEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TEM Per share dataTEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • TEM's earnings are expected to grow with 28.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.63%
EPS Next 3Y28.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TEM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TEMPUS AI INC

NASDAQ:TEM (2/6/2026, 12:03:09 PM)

55.19

+2.75 (+5.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)02-17
Inst Owners51.7%
Inst Owner Change5.47%
Ins Owners7.45%
Ins Owner Change-1.1%
Market Cap9.82B
Revenue(TTM)1.11B
Net Income(TTM)-203.88M
Analysts76.84
Price Target90.33 (63.67%)
Short Float %20.69%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.63%
Min EPS beat(2)10.18%
Max EPS beat(2)35.09%
EPS beat(4)4
Avg EPS beat(4)18.42%
Min EPS beat(4)10.18%
Max EPS beat(4)35.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)0.66%
Max Revenue beat(2)4.94%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-2.18%
Max Revenue beat(4)4.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.29%
PT rev (3m)3.6%
EPS NQ rev (1m)7.5%
EPS NQ rev (3m)62.16%
EPS NY rev (1m)0%
EPS NY rev (3m)14.79%
Revenue NQ rev (1m)0.28%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.88
P/FCF N/A
P/OCF N/A
P/B 19.34
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS6.21
BVpS2.85
TBVpS-1.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.94%
ROE -40.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.73%
FCFM N/A
ROA(3y)-60.21%
ROA(5y)-54.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y16.28%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.04%
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 3.12
Altman-Z 2.27
F-Score3
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)74.55%
Cap/Depr(5y)66.22%
Cap/Sales(3y)5.14%
Cap/Sales(5y)5.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56%
EPS Next Y75.39%
EPS Next 2Y35.63%
EPS Next 3Y28.93%
EPS Next 5Y24.74%
Revenue 1Y (TTM)72.58%
Revenue growth 3Y39.06%
Revenue growth 5Y62.05%
Sales Q2Q%84.72%
Revenue Next Year81.58%
Revenue Next 2Y50.22%
Revenue Next 3Y39.5%
Revenue Next 5Y32.7%
EBIT growth 1Y65.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.11%
EBIT Next 3Y42.61%
EBIT Next 5Y34.62%
FCF growth 1Y15.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.8%
OCF growth 3YN/A
OCF growth 5YN/A

TEMPUS AI INC / TEM FAQ

What is the fundamental rating for TEM stock?

ChartMill assigns a fundamental rating of 3 / 10 to TEM.


Can you provide the valuation status for TEMPUS AI INC?

ChartMill assigns a valuation rating of 1 / 10 to TEMPUS AI INC (TEM). This can be considered as Overvalued.


What is the profitability of TEM stock?

TEMPUS AI INC (TEM) has a profitability rating of 2 / 10.


What is the earnings growth outlook for TEMPUS AI INC?

The Earnings per Share (EPS) of TEMPUS AI INC (TEM) is expected to grow by 75.39% in the next year.